Marcus Lind

Summary

Country: Sweden

Publications

  1. doi request reprint Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Thromb Res 129:32-5. 2012
  2. doi request reprint The effect of insulin lispro on glycemic control in a large patient cohort
    Marcus Lind
    Department of Medicine, Uddevalla Hospital, Sweden
    Diabetes Technol Ther 11:51-6. 2009
  3. doi request reprint Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
    Marcus Lind
    Institute of Medicine, University of Gothenburg, Gothenburg, Sweden Department of Medicine, Uddevalla Hospital, NU Hospital Group, 451 80 Uddevalla, Sweden
    BMJ 351:h5364. 2015
  4. doi request reprint Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial)
    Marcus Lind
    Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden Department of Medicine, NU Hospital Organization, Uddevalla, Sweden Electronic address
    Prim Care Diabetes 9:15-22. 2015
  5. doi request reprint Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK
    Marcus Lind
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Diabetologia 57:1586-94. 2014
  6. doi request reprint Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
    M Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Diabetologia 56:2601-8. 2013
  7. doi request reprint Incretin therapy and its effect on body weight in patients with diabetes
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:187-91. 2012
  8. doi request reprint The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes
    M Lind
    Department of Medicine, Uddevalla Hospital, 451 80 Uddevalla, Sweden
    Diabetologia 55:2946-53. 2012
  9. doi request reprint Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:41-6. 2012
  10. doi request reprint The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
    Marcus Lind
    Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:53-9. 2012

Collaborators

Detail Information

Publications26

  1. doi request reprint Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Thromb Res 129:32-5. 2012
    ..0-3.0. Our aim was to study whether INR variability, as assessed by the standard deviation of transformed INR (SDT(INR)) is more prognostically important than the TTR...
  2. doi request reprint The effect of insulin lispro on glycemic control in a large patient cohort
    Marcus Lind
    Department of Medicine, Uddevalla Hospital, Sweden
    Diabetes Technol Ther 11:51-6. 2009
    ..We therefore studied how glycemic control has been affected by using insulin lispro in clinical practice over 5 years in 14 hospitals in Sweden...
  3. doi request reprint Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)
    Marcus Lind
    Institute of Medicine, University of Gothenburg, Gothenburg, Sweden Department of Medicine, Uddevalla Hospital, NU Hospital Group, 451 80 Uddevalla, Sweden
    BMJ 351:h5364. 2015
    ..What are the effects of liraglutide, an incretin based treatment, on glycaemic control in people with type 2 diabetes treated with multiple daily insulin injections?..
  4. doi request reprint Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial)
    Marcus Lind
    Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden Department of Medicine, NU Hospital Organization, Uddevalla, Sweden Electronic address
    Prim Care Diabetes 9:15-22. 2015
    ..The aim of this study is to evaluate the effect of GLP-1 analogue liraglutide on glycaemic control in patients with type 2 diabetes treated with MDI with inadequate glycaemic control...
  5. doi request reprint Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK
    Marcus Lind
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Diabetologia 57:1586-94. 2014
    ..The aim of this work was to study levels of HbA1c and patterns of adjusting glucose-lowering drugs in patients with impaired glycaemic control over 10 years after diagnosis of type 2 diabetes...
  6. doi request reprint Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
    M Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Diabetologia 56:2601-8. 2013
    ..The aim of this study was to determine the contemporary rate ratio of mortality and changes over time in individuals with vs without diabetes...
  7. doi request reprint Incretin therapy and its effect on body weight in patients with diabetes
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:187-91. 2012
    ....
  8. doi request reprint The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes
    M Lind
    Department of Medicine, Uddevalla Hospital, 451 80 Uddevalla, Sweden
    Diabetologia 55:2946-53. 2012
    ..The aim of this study was to examine the relationship between glycaemic control and hospitalisation for heart failure in patients with type 2 diabetes...
  9. doi request reprint Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:41-6. 2012
    ..To evaluate the effects of adding glucagon-like peptide-1 (GLP-1) analogue therapy to insulin on glycated hemoglobin (HbA1c), weight, insulin dosage, treatment satisfaction, and risk of hypoglycaemia...
  10. doi request reprint The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
    Marcus Lind
    Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Prim Care Diabetes 6:53-9. 2012
    ..To elucidate methodological questions in assessing the relationship between insulin treatment and cancer, since the risk of tumour growth generally increases with longer exposure time and higher dose of a growth promoting substance...
  11. doi request reprint Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study
    Marcus Lind
    Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Lancet 378:140-6. 2011
    ..We aimed to assess this association in a large cohort of patients with type 1 diabetes identified from the Swedish national diabetes registry...
  12. doi request reprint The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects
    M Lind
    Department of Medicine, NU Hospital Organization, SE 451 80 Uddevalla, Sweden
    Diabetologia 53:1093-8. 2010
    ..We determined the shape of the metabolic memory of HbA1c and its contribution to retinopathy, as well as the importance of reducing HbA1c to prevent progression of retinopathy...
  13. pmc The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables
    Marcus Lind
    Department of Medicine, Uddevalla Hospital, Uddevalla, Sweden
    PLoS ONE 4:e4412. 2009
    ..We studied whether the updated mean HbA1c underestimated the risk of diabetic complications...
  14. pmc Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice
    Jenny Anderson
    Department of Medicine, NU Hospital Organization, Trollhattan, Sweden
    J Diabetes Sci Technol 5:1472-9. 2011
    ..The effects of CGM on glycemic control in clinical practice in relation to indication and duration of use has not been completely studied...
  15. doi request reprint Excess Mortality among Persons with Type 2 Diabetes
    Mauro Tancredi
    From the Department of Molecular and Clinical Medicine, University of Gothenburg M T, A R, S G, M L, Center of Registers in Region Västra Götaland A M S, Statistiska Konsultgruppen A P, and Nordic School of Public Health H W, Gothenburg, and the Department of Medicine, NU Hospital Group, Trollhättan and Uddevalla M T, S D, M L all in Sweden Saint Luke s Mid America Heart Institute M K and Children s Mercy Hospital M C, University of Missouri Kansas City School of Medicine, Kansas City and the University of Kansas School of Medicine, Kansas City M C
    N Engl J Med 373:1720-32. 2015
    ..In this registry-based study, we assessed these risks according to glycemic control and renal complications among persons with type 2 diabetes...
  16. doi request reprint Glycemic control and excess mortality in type 1 diabetes
    Marcus Lind
    From the Department of Medicine, NU Hospital Organization, Uddevalla M L, S D, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg M L, S G, A R, Center of Registers in Region Västra Götaland A M S, Statistiska Konsultgruppen A P, Nordic School of Public Health H W, and Sahlgrenska University Hospital A R, Gothenburg all in Sweden Saint Luke s Mid America Heart Institute M K, University of Missouri Kansas City School of Medicine M K, M C, and Children s Mercy Hospital M C, Kansas City, MO and the University of Kansas School of Medicine, Kansas City, KS M C
    N Engl J Med 371:1972-82. 2014
    ..We conducted a registry-based observational study to determine the excess risk of death according to the level of glycemic control in a Swedish population of patients with diabetes...
  17. doi request reprint Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study
    Annika Rosengren
    Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital Östra Hospital, Gothenburg, Sweden Electronic address
    Lancet Diabetes Endocrinol 3:876-85. 2015
    ..We aimed to determine the excess risk of heart failure in individuals with type 1 diabetes overall and by different levels of glycaemic control and albuminuria...
  18. doi request reprint Decreased eGFR as a Risk Factor for Heart Failure in 13 781 Individuals With Type 1 Diabetes
    Daniel Vestberg
    Department of Medicine, NU Hospital Organisation, Region Västra Götaland, Sweden Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    J Diabetes Sci Technol 10:131-6. 2015
    ..The aim of our study was to quantify the risk increase for development of heart failure with decreasing kidney function in individuals with type 1 diabetes...
  19. pmc Relationship between overweight and obesity with hospitalization for heart failure in 20,985 patients with type 1 diabetes: a population-based study from the Swedish National Diabetes Registry
    Daniel Vestberg
    Department of Medicine, NU Hospital Organization, Sweden
    Diabetes Care 36:2857-61. 2013
    ..To investigate the potential relationship between overweight, obesity, and severe obesity and the risk of hospitalization for heart failure (HF) in patients with type 1 diabetes...
  20. doi request reprint Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden
    Britt Marie Carlsson
    Department of Medicine, SÄS Hospital Organization, Skene, Sweden
    Diabetes Technol Ther 15:302-7. 2013
    ..This study examined long-term effects of continuous subcutaneous insulin infusion (CSII) in clinical practice on glycemic control in patients with type 1 diabetes...
  21. doi request reprint Thrombomodulin as a marker for bleeding complications during warfarin treatment
    Marcus Lind
    Department of Medicine, Skellefteå County Hospital, Skellefteå, Sweden
    Arch Intern Med 169:1210-5. 2009
    ..This study aimed to test if thrombomodulin (TM) concentrations were associated with bleeding complications, cardiovascular events, or mortality in long-term anticoagulant-treated patients...
  22. doi request reprint The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial
    Linda G Mellbin
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Eur Heart J 34:374-9. 2013
    ..The present aim was to study the possibility of such a relation in patients with type 2 diabetes (T2DM) and AMI...
  23. pmc A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes
    Viktorija Matuleviciene
    1 Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
    Diabetes Technol Ther 16:759-67. 2014
    ..The purpose of the current study was to evaluate whether accuracy and patient treatment satisfaction differ between the Enlite™ (Medtronic MiniMed, Inc., Northridge, CA) and Dexcom(®) (San Diego, CA) G4 PLATINUM CGM sensors...
  24. pmc The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes
    Marcus Lind
    Institute of Medicine, Sahlgrenska Academy University of Gothenburg, Gothenburg, Sweden
    PLoS ONE 9:e109506. 2014
    ..To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour (2 hPG) glucose after an oral glucose tolerance test (OGTT) and cardiovascular disease in individuals with elevated risk for diabetes...
  25. doi request reprint Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes
    Marita Olsson
    R and D AstraZeneca, Molndal, Sweden Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden
    Diabetes Care 38:1481-6. 2015
    ..This study evaluated the risk of myocardial infarction (MI) by impaired glycemic control in a contemporary large cohort of patients with type 2 diabetes followed from diagnosis...